midazolam and fk1706
midazolam has been researched along with fk1706 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hori, K; Ishibashi, K; Kamimura, H; Kowalski, D; Lee, J; Minematsu, T; Moy, S; Usui, T; Zha, J | 1 |
Trials
1 trial(s) available for midazolam and fk1706
| Article | Year |
|---|---|
Time-dependent inhibitory effects of (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(2-oxopropyl)-11,28-dioxa-4-azatricyclo[22.3.1
Topics: Adolescent; Adult; Computer Simulation; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Humans; Immunophilins; Ligands; Male; Microsomes, Liver; Midazolam; Middle Aged; Models, Biological; Tacrolimus; Time Factors; Young Adult | 2010 |